Article
Myovant Up on $4.2B Pfizer Pact to Develop Prostate-Cancer Drug
Rating:
0.0
Views:
75
Likes:
1
Library:
1
Myovant and Pfizer will develop Orgovyx for advanced prostate cancer and, if approved, a combination tablet that includes the drug in women's health.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value